Global Genetic Modification Therapies Market Growth (Status and Outlook) 2025-2031
According to this study, the global Genetic Modification Therapies market size will reach US$ million by 2031.
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Genetic Modification Therapies Industry Forecast” looks at past sales and reviews total world Genetic Modification Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetic Modification Therapies sales for 2025 through 2031. With Genetic Modification Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Modification Therapies industry.
This Insight Report provides a comprehensive analysis of the global Genetic Modification Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Modification Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Modification Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Modification Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Modification Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Modification Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Genetic Modification Therapies Industry Forecast” looks at past sales and reviews total world Genetic Modification Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetic Modification Therapies sales for 2025 through 2031. With Genetic Modification Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Modification Therapies industry.
This Insight Report provides a comprehensive analysis of the global Genetic Modification Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Modification Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Modification Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Modification Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Modification Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Modification Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Gene Therapies
- Genetically Modified Cell Therapies
- RNA Therapies
- Gene Editing
- Hospitals
- Diagnostics and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 4D Molecular Therapeutics
- Abeona Therapeutics
- Allergan
- American Gene Technologies
- Merck Millipore
- AbbVie
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Modification Therapies Market Size (2020-2031)
2.1.2 Genetic Modification Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Genetic Modification Therapies by Country/Region (2020, 2024 & 2031)
2.2 Genetic Modification Therapies Segment by Type
2.2.1 Gene Therapies
2.2.2 Genetically Modified Cell Therapies
2.2.3 RNA Therapies
2.2.4 Gene Editing
2.3 Genetic Modification Therapies Market Size by Type
2.3.1 Genetic Modification Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
2.4 Genetic Modification Therapies Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Genetic Modification Therapies Market Size by Application
2.5.1 Genetic Modification Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
3 GENETIC MODIFICATION THERAPIES MARKET SIZE BY PLAYER
3.1 Genetic Modification Therapies Market Size Market Share by Player
3.1.1 Global Genetic Modification Therapies Revenue by Player (2020-2025)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Player (2020-2025)
3.2 Global Genetic Modification Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC MODIFICATION THERAPIES BY REGION
4.1 Genetic Modification Therapies Market Size by Region (2020-2025)
4.2 Global Genetic Modification Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genetic Modification Therapies Market Size Growth (2020-2025)
4.4 APAC Genetic Modification Therapies Market Size Growth (2020-2025)
4.5 Europe Genetic Modification Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Genetic Modification Therapies Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Genetic Modification Therapies Market Size by Country (2020-2025)
5.2 Americas Genetic Modification Therapies Market Size by Type (2020-2025)
5.3 Americas Genetic Modification Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Modification Therapies Market Size by Region (2020-2025)
6.2 APAC Genetic Modification Therapies Market Size by Type (2020-2025)
6.3 APAC Genetic Modification Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Modification Therapies Market Size by Country (2020-2025)
7.2 Europe Genetic Modification Therapies Market Size by Type (2020-2025)
7.3 Europe Genetic Modification Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Modification Therapies by Region (2020-2025)
8.2 Middle East & Africa Genetic Modification Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Genetic Modification Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC MODIFICATION THERAPIES MARKET FORECAST
10.1 Global Genetic Modification Therapies Forecast by Region (2026-2031)
10.1.1 Global Genetic Modification Therapies Forecast by Region (2026-2031)
10.1.2 Americas Genetic Modification Therapies Forecast
10.1.3 APAC Genetic Modification Therapies Forecast
10.1.4 Europe Genetic Modification Therapies Forecast
10.1.5 Middle East & Africa Genetic Modification Therapies Forecast
10.2 Americas Genetic Modification Therapies Forecast by Country (2026-2031)
10.2.1 United States Market Genetic Modification Therapies Forecast
10.2.2 Canada Market Genetic Modification Therapies Forecast
10.2.3 Mexico Market Genetic Modification Therapies Forecast
10.2.4 Brazil Market Genetic Modification Therapies Forecast
10.3 APAC Genetic Modification Therapies Forecast by Region (2026-2031)
10.3.1 China Genetic Modification Therapies Market Forecast
10.3.2 Japan Market Genetic Modification Therapies Forecast
10.3.3 Korea Market Genetic Modification Therapies Forecast
10.3.4 Southeast Asia Market Genetic Modification Therapies Forecast
10.3.5 India Market Genetic Modification Therapies Forecast
10.3.6 Australia Market Genetic Modification Therapies Forecast
10.4 Europe Genetic Modification Therapies Forecast by Country (2026-2031)
10.4.1 Germany Market Genetic Modification Therapies Forecast
10.4.2 France Market Genetic Modification Therapies Forecast
10.4.3 UK Market Genetic Modification Therapies Forecast
10.4.4 Italy Market Genetic Modification Therapies Forecast
10.4.5 Russia Market Genetic Modification Therapies Forecast
10.5 Middle East & Africa Genetic Modification Therapies Forecast by Region (2026-2031)
10.5.1 Egypt Market Genetic Modification Therapies Forecast
10.5.2 South Africa Market Genetic Modification Therapies Forecast
10.5.3 Israel Market Genetic Modification Therapies Forecast
10.5.4 Turkey Market Genetic Modification Therapies Forecast
10.6 Global Genetic Modification Therapies Forecast by Type (2026-2031)
10.7 Global Genetic Modification Therapies Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Genetic Modification Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Information
11.1.2 4D Molecular Therapeutics Genetic Modification Therapies Product Offered
11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 4D Molecular Therapeutics Main Business Overview
11.1.5 4D Molecular Therapeutics Latest Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Company Information
11.2.2 Abeona Therapeutics Genetic Modification Therapies Product Offered
11.2.3 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Abeona Therapeutics Main Business Overview
11.2.5 Abeona Therapeutics Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Genetic Modification Therapies Product Offered
11.3.3 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Information
11.4.2 American Gene Technologies Genetic Modification Therapies Product Offered
11.4.3 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 American Gene Technologies Main Business Overview
11.4.5 American Gene Technologies Latest Developments
11.5 Merck Millipore
11.5.1 Merck Millipore Company Information
11.5.2 Merck Millipore Genetic Modification Therapies Product Offered
11.5.3 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Millipore Main Business Overview
11.5.5 Merck Millipore Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Genetic Modification Therapies Product Offered
11.6.3 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Modification Therapies Market Size (2020-2031)
2.1.2 Genetic Modification Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Genetic Modification Therapies by Country/Region (2020, 2024 & 2031)
2.2 Genetic Modification Therapies Segment by Type
2.2.1 Gene Therapies
2.2.2 Genetically Modified Cell Therapies
2.2.3 RNA Therapies
2.2.4 Gene Editing
2.3 Genetic Modification Therapies Market Size by Type
2.3.1 Genetic Modification Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
2.4 Genetic Modification Therapies Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 Genetic Modification Therapies Market Size by Application
2.5.1 Genetic Modification Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
3 GENETIC MODIFICATION THERAPIES MARKET SIZE BY PLAYER
3.1 Genetic Modification Therapies Market Size Market Share by Player
3.1.1 Global Genetic Modification Therapies Revenue by Player (2020-2025)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Player (2020-2025)
3.2 Global Genetic Modification Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC MODIFICATION THERAPIES BY REGION
4.1 Genetic Modification Therapies Market Size by Region (2020-2025)
4.2 Global Genetic Modification Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genetic Modification Therapies Market Size Growth (2020-2025)
4.4 APAC Genetic Modification Therapies Market Size Growth (2020-2025)
4.5 Europe Genetic Modification Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Genetic Modification Therapies Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Genetic Modification Therapies Market Size by Country (2020-2025)
5.2 Americas Genetic Modification Therapies Market Size by Type (2020-2025)
5.3 Americas Genetic Modification Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Modification Therapies Market Size by Region (2020-2025)
6.2 APAC Genetic Modification Therapies Market Size by Type (2020-2025)
6.3 APAC Genetic Modification Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Modification Therapies Market Size by Country (2020-2025)
7.2 Europe Genetic Modification Therapies Market Size by Type (2020-2025)
7.3 Europe Genetic Modification Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Modification Therapies by Region (2020-2025)
8.2 Middle East & Africa Genetic Modification Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Genetic Modification Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC MODIFICATION THERAPIES MARKET FORECAST
10.1 Global Genetic Modification Therapies Forecast by Region (2026-2031)
10.1.1 Global Genetic Modification Therapies Forecast by Region (2026-2031)
10.1.2 Americas Genetic Modification Therapies Forecast
10.1.3 APAC Genetic Modification Therapies Forecast
10.1.4 Europe Genetic Modification Therapies Forecast
10.1.5 Middle East & Africa Genetic Modification Therapies Forecast
10.2 Americas Genetic Modification Therapies Forecast by Country (2026-2031)
10.2.1 United States Market Genetic Modification Therapies Forecast
10.2.2 Canada Market Genetic Modification Therapies Forecast
10.2.3 Mexico Market Genetic Modification Therapies Forecast
10.2.4 Brazil Market Genetic Modification Therapies Forecast
10.3 APAC Genetic Modification Therapies Forecast by Region (2026-2031)
10.3.1 China Genetic Modification Therapies Market Forecast
10.3.2 Japan Market Genetic Modification Therapies Forecast
10.3.3 Korea Market Genetic Modification Therapies Forecast
10.3.4 Southeast Asia Market Genetic Modification Therapies Forecast
10.3.5 India Market Genetic Modification Therapies Forecast
10.3.6 Australia Market Genetic Modification Therapies Forecast
10.4 Europe Genetic Modification Therapies Forecast by Country (2026-2031)
10.4.1 Germany Market Genetic Modification Therapies Forecast
10.4.2 France Market Genetic Modification Therapies Forecast
10.4.3 UK Market Genetic Modification Therapies Forecast
10.4.4 Italy Market Genetic Modification Therapies Forecast
10.4.5 Russia Market Genetic Modification Therapies Forecast
10.5 Middle East & Africa Genetic Modification Therapies Forecast by Region (2026-2031)
10.5.1 Egypt Market Genetic Modification Therapies Forecast
10.5.2 South Africa Market Genetic Modification Therapies Forecast
10.5.3 Israel Market Genetic Modification Therapies Forecast
10.5.4 Turkey Market Genetic Modification Therapies Forecast
10.6 Global Genetic Modification Therapies Forecast by Type (2026-2031)
10.7 Global Genetic Modification Therapies Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Genetic Modification Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Information
11.1.2 4D Molecular Therapeutics Genetic Modification Therapies Product Offered
11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 4D Molecular Therapeutics Main Business Overview
11.1.5 4D Molecular Therapeutics Latest Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Company Information
11.2.2 Abeona Therapeutics Genetic Modification Therapies Product Offered
11.2.3 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Abeona Therapeutics Main Business Overview
11.2.5 Abeona Therapeutics Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Genetic Modification Therapies Product Offered
11.3.3 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Information
11.4.2 American Gene Technologies Genetic Modification Therapies Product Offered
11.4.3 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 American Gene Technologies Main Business Overview
11.4.5 American Gene Technologies Latest Developments
11.5 Merck Millipore
11.5.1 Merck Millipore Company Information
11.5.2 Merck Millipore Genetic Modification Therapies Product Offered
11.5.3 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Millipore Main Business Overview
11.5.5 Merck Millipore Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Genetic Modification Therapies Product Offered
11.6.3 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetic Modification Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Genetic Modification Therapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gene Therapies
Table 4. Major Players of Genetically Modified Cell Therapies
Table 5. Major Players of RNA Therapies
Table 6. Major Players of Gene Editing
Table 7. Genetic Modification Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Table 10. Genetic Modification Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Table 13. Global Genetic Modification Therapies Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Genetic Modification Therapies Revenue Market Share by Player (2020-2025)
Table 15. Genetic Modification Therapies Key Players Head office and Products Offered
Table 16. Genetic Modification Therapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Table 21. Global Genetic Modification Therapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Genetic Modification Therapies Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Genetic Modification Therapies Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Genetic Modification Therapies Market Size Market Share by Country (2020-2025)
Table 25. Americas Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Table 27. Americas Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Table 29. APAC Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Table 31. APAC Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Genetic Modification Therapies Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Genetic Modification Therapies Market Size Market Share by Country (2020-2025)
Table 35. Europe Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Modification Therapies
Table 41. Key Market Challenges & Risks of Genetic Modification Therapies
Table 42. Key Industry Trends of Genetic Modification Therapies
Table 43. Global Genetic Modification Therapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Genetic Modification Therapies Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Genetic Modification Therapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Genetic Modification Therapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. 4D Molecular Therapeutics Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 48. 4D Molecular Therapeutics Genetic Modification Therapies Product Offered
Table 49. 4D Molecular Therapeutics Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. 4D Molecular Therapeutics Main Business
Table 51. 4D Molecular Therapeutics Latest Developments
Table 52. Abeona Therapeutics Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 53. Abeona Therapeutics Genetic Modification Therapies Product Offered
Table 54. Abeona Therapeutics Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Abeona Therapeutics Main Business
Table 56. Abeona Therapeutics Latest Developments
Table 57. Allergan Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 58. Allergan Genetic Modification Therapies Product Offered
Table 59. Allergan Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Allergan Main Business
Table 61. Allergan Latest Developments
Table 62. American Gene Technologies Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 63. American Gene Technologies Genetic Modification Therapies Product Offered
Table 64. American Gene Technologies Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. American Gene Technologies Main Business
Table 66. American Gene Technologies Latest Developments
Table 67. Merck Millipore Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 68. Merck Millipore Genetic Modification Therapies Product Offered
Table 69. Merck Millipore Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Merck Millipore Main Business
Table 71. Merck Millipore Latest Developments
Table 72. AbbVie Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 73. AbbVie Genetic Modification Therapies Product Offered
Table 74. AbbVie Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 1. Genetic Modification Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Genetic Modification Therapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gene Therapies
Table 4. Major Players of Genetically Modified Cell Therapies
Table 5. Major Players of RNA Therapies
Table 6. Major Players of Gene Editing
Table 7. Genetic Modification Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Table 10. Genetic Modification Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Table 13. Global Genetic Modification Therapies Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Genetic Modification Therapies Revenue Market Share by Player (2020-2025)
Table 15. Genetic Modification Therapies Key Players Head office and Products Offered
Table 16. Genetic Modification Therapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Table 21. Global Genetic Modification Therapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Genetic Modification Therapies Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Genetic Modification Therapies Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Genetic Modification Therapies Market Size Market Share by Country (2020-2025)
Table 25. Americas Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Table 27. Americas Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Table 29. APAC Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Table 31. APAC Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Genetic Modification Therapies Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Genetic Modification Therapies Market Size Market Share by Country (2020-2025)
Table 35. Europe Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Genetic Modification Therapies Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Genetic Modification Therapies Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Genetic Modification Therapies Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Modification Therapies
Table 41. Key Market Challenges & Risks of Genetic Modification Therapies
Table 42. Key Industry Trends of Genetic Modification Therapies
Table 43. Global Genetic Modification Therapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Genetic Modification Therapies Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Genetic Modification Therapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Genetic Modification Therapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. 4D Molecular Therapeutics Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 48. 4D Molecular Therapeutics Genetic Modification Therapies Product Offered
Table 49. 4D Molecular Therapeutics Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. 4D Molecular Therapeutics Main Business
Table 51. 4D Molecular Therapeutics Latest Developments
Table 52. Abeona Therapeutics Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 53. Abeona Therapeutics Genetic Modification Therapies Product Offered
Table 54. Abeona Therapeutics Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Abeona Therapeutics Main Business
Table 56. Abeona Therapeutics Latest Developments
Table 57. Allergan Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 58. Allergan Genetic Modification Therapies Product Offered
Table 59. Allergan Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Allergan Main Business
Table 61. Allergan Latest Developments
Table 62. American Gene Technologies Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 63. American Gene Technologies Genetic Modification Therapies Product Offered
Table 64. American Gene Technologies Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. American Gene Technologies Main Business
Table 66. American Gene Technologies Latest Developments
Table 67. Merck Millipore Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 68. Merck Millipore Genetic Modification Therapies Product Offered
Table 69. Merck Millipore Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Merck Millipore Main Business
Table 71. Merck Millipore Latest Developments
Table 72. AbbVie Details, Company Type, Genetic Modification Therapies Area Served and Its Competitors
Table 73. AbbVie Genetic Modification Therapies Product Offered
Table 74. AbbVie Genetic Modification Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Genetic Modification Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Modification Therapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Genetic Modification Therapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Genetic Modification Therapies Sales Market Share by Country/Region (2024)
Figure 8. Genetic Modification Therapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Genetic Modification Therapies Market Size Market Share by Type in 2024
Figure 10. Genetic Modification Therapies in Hospitals
Figure 11. Global Genetic Modification Therapies Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Genetic Modification Therapies in Diagnostics and Testing Laboratories
Figure 13. Global Genetic Modification Therapies Market: Diagnostics and Testing Laboratories (2020-2025) & ($ millions)
Figure 14. Genetic Modification Therapies in Academic and Research Organizations
Figure 15. Global Genetic Modification Therapies Market: Academic and Research Organizations (2020-2025) & ($ millions)
Figure 16. Genetic Modification Therapies in Others
Figure 17. Global Genetic Modification Therapies Market: Others (2020-2025) & ($ millions)
Figure 18. Global Genetic Modification Therapies Market Size Market Share by Application in 2024
Figure 19. Global Genetic Modification Therapies Revenue Market Share by Player in 2024
Figure 20. Global Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Figure 21. Americas Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 22. APAC Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 23. Europe Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 25. Americas Genetic Modification Therapies Value Market Share by Country in 2024
Figure 26. United States Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Genetic Modification Therapies Market Size Market Share by Region in 2024
Figure 31. APAC Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 32. APAC Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 33. China Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 37. India Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Genetic Modification Therapies Market Size Market Share by Country in 2024
Figure 40. Europe Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 41. Europe Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 42. Germany Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 43. France Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 56. APAC Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 57. Europe Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 59. United States Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 60. Canada Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 61. Mexico Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 62. Brazil Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 63. China Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 64. Japan Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 65. Korea Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 67. India Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 68. Australia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 69. Germany Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 70. France Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 71. UK Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 72. Italy Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 73. Russia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 74. Egypt Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 75. South Africa Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 76. Israel Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 77. Turkey Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 78. Global Genetic Modification Therapies Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Genetic Modification Therapies Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 1. Genetic Modification Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Modification Therapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Genetic Modification Therapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Genetic Modification Therapies Sales Market Share by Country/Region (2024)
Figure 8. Genetic Modification Therapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Genetic Modification Therapies Market Size Market Share by Type in 2024
Figure 10. Genetic Modification Therapies in Hospitals
Figure 11. Global Genetic Modification Therapies Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Genetic Modification Therapies in Diagnostics and Testing Laboratories
Figure 13. Global Genetic Modification Therapies Market: Diagnostics and Testing Laboratories (2020-2025) & ($ millions)
Figure 14. Genetic Modification Therapies in Academic and Research Organizations
Figure 15. Global Genetic Modification Therapies Market: Academic and Research Organizations (2020-2025) & ($ millions)
Figure 16. Genetic Modification Therapies in Others
Figure 17. Global Genetic Modification Therapies Market: Others (2020-2025) & ($ millions)
Figure 18. Global Genetic Modification Therapies Market Size Market Share by Application in 2024
Figure 19. Global Genetic Modification Therapies Revenue Market Share by Player in 2024
Figure 20. Global Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Figure 21. Americas Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 22. APAC Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 23. Europe Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Genetic Modification Therapies Market Size 2020-2025 ($ millions)
Figure 25. Americas Genetic Modification Therapies Value Market Share by Country in 2024
Figure 26. United States Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Genetic Modification Therapies Market Size Market Share by Region in 2024
Figure 31. APAC Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 32. APAC Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 33. China Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 37. India Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Genetic Modification Therapies Market Size Market Share by Country in 2024
Figure 40. Europe Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 41. Europe Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 42. Germany Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 43. France Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Genetic Modification Therapies Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Genetic Modification Therapies Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 56. APAC Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 57. Europe Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 59. United States Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 60. Canada Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 61. Mexico Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 62. Brazil Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 63. China Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 64. Japan Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 65. Korea Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 67. India Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 68. Australia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 69. Germany Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 70. France Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 71. UK Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 72. Italy Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 73. Russia Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 74. Egypt Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 75. South Africa Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 76. Israel Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 77. Turkey Genetic Modification Therapies Market Size 2026-2031 ($ millions)
Figure 78. Global Genetic Modification Therapies Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Genetic Modification Therapies Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Genetic Modification Therapies Market Size 2026-2031 ($ millions)
